Meeting Details
- Meeting Date: Saturday, 08th August, 2026
- Mode: Video Conferencing
- Location: Corporate office of the Company
Agenda Items
1. To consider and approve the limited reviewed financial results for the first quarter ended 30th June, 2026, together with the limited review report from the statutory auditor.
2. To consider and potentially approve fundraising through issuance of Equity shares/Share Warrants and/or any other eligible securities on a preferential basis to one or more persons. This would be conducted in accordance with:
- Companies Act, 2013 and rules thereunder
- SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
- Subject to shareholder approval and required regulatory/statutory approvals
3. To consider and approve enhancement in the umbrella limit for issuance of Non-Convertible Debentures (NCDs) on a private placement basis, within the overall borrowing limits of the Company. This is subject to shareholder approval and other required approvals.
4. To consider any other matter with permission of Chairman and consent of majority of Directors present.
Trading Window Update
In continuation of the intimation communicated on 25th June, 2026, the Trading Window for dealing in equity shares will re-open after completion of forty-eight (48) hours after declaration of limited reviewed Financial Results for the quarter ended 30th June, 2026. The reopening date is specified as Tuesday, 11th August, 2026. This applies to all Designated Persons, Directors, Key Managerial Personnel and their immediate relatives.